8-KThe WireRoutine
Bylaw Amendment
Filed Sep 16, 2024 · 1y ago · Accession 0001193125-24-219617
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Bicara Therapeutics Inc.
- Ticker
- BCAX
- CIK
- 2023658
- Form type
- 8-K
- Filing date
- Sep 16, 2024
- Report date
- Sep 12, 2024
- Document
- d844648d8k.htm
- Size
- 169 KB